Skip to main content
70°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
88.28
+1.66 (+1.91%)
Streaming Delayed Price
Updated: 11:16 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
March 05, 2024
The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.
Via
InvestorPlace
Unpacking the Latest Options Trading Trends in Moderna
March 04, 2024
Via
Benzinga
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential
March 04, 2024
Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Novavax a Buy Now?
March 04, 2024
The stock has dropped 98% over the past three years.
Via
The Motley Fool
Where Will Moderna Stock Be in 5 Years?
March 03, 2024
Can Moderna be a good stock to buy if it can no longer count on billions in revenue from its COVID vaccine?
Via
The Motley Fool
Exposures
COVID-19
5 Top Stocks to Buy in March
March 03, 2024
This basket of growth, income, and value has a little something for everyone.
Via
The Motley Fool
3 Reasons to Buy Moderna Stock
March 02, 2024
The company can still deliver excellent returns.
Via
The Motley Fool
This Is What Whales Are Betting On Moderna
February 29, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
February 28, 2024
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, March 2
March 02, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 26 through March 1.
Via
Talk Markets
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
These three stocks have two important common denominators: the same industry and tremendous growth prospects.
Via
The Motley Fool
Got $200? 2 Dividend Stocks to Buy and Hold Forever
March 01, 2024
Trust these two real estate stocks to be attractively priced and proven performers.
Via
The Motley Fool
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
February 29, 2024
The futures for these two beaten-down stocks could be brighter than their recent pasts.
Via
The Motley Fool
Earnings Seasons Score Card: 4 Stock Superstars and 3 That Fell Short
February 28, 2024
Watch these companies, whose share prices have seen big swings higher or lower after they reported Q4 2023 earnings.
Via
InvestorPlace
Where Moderna Stands With Analysts
February 23, 2024
Via
Benzinga
Why Moderna Stock Is Jumping Today
February 22, 2024
The biotech company surprised investors with a Q4 profit.
Via
The Motley Fool
Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening
February 28, 2024
When it comes to cancer, one cannot overestimate the importance of early detection. Especially when it comes to colorectal and endometrial cancer that even big pharma companies don’t have a good track...
Via
Benzinga
Moderna Stock Has 33% Upside, According to 1 Wall Street Analyst
February 28, 2024
A lot is riding on whether there will be demand for its new vaccines.
Via
The Motley Fool
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Block To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Monday
February 26, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Moderna (MRNA) Q4 2023 Earnings Call Transcript
February 22, 2024
MRNA earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
February 22, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna Posts Quarterly Profit Despite Lower Sales From COVID-19 Vaccine
February 22, 2024
Moderna reports Q4 2023 revenues of $2.81 billion from Spikevax (COVID-19 vaccine), exceeding expectations.
Via
Benzinga
Exposures
COVID-19
Moderna’s Unexpected $217 Million Profit Marks A Surprising Q4 Achievement
February 22, 2024
Moderna Inc. showcased a resilient fourth-quarter performance for the fiscal year 2023, navigating through the challenges posed by the transition to an endemic market environment.
Via
Talk Markets
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
February 22, 2024
Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speeches, weekly jobless claims data, and private-sector activity readings.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Range-Bound Moderna Could Get A Boost On Its Fourth-Quarter Report
February 22, 2024
The company unexpectedly came in with fourth-quarter earnings that beat projections.
Via
Investor's Business Daily
Moderna Likely To Report Q4 Loss; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 22, 2024
Moderna, Inc. (NASDAQ: MRNA) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 22, 2024.
Via
Benzinga
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
Moderna reports Q4 earnings on Feb. 22. Analysts expect $2.53B in revenue. Stock has faced challenges but potential for recovery with COVID-19 vaccine and FDA approval in 2024.
Via
Benzinga
Exposures
COVID-19
Product Safety
Earnings Scheduled For February 22, 2024
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.